BDBM453331 BDBM553834::US10730826, Compound 55a

SMILES NCCCCC(NC(=O)c1ccc(F)nc1)C(=O)COc1ccon1

InChI Key InChIKey=BQOGBOZVNFTTKQ-UHFFFAOYSA-N

Data  14 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 14 hits for monomerid = 453331   

TargetLys-gingipain W83(Porphyromonas gingivalis)
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50:  0.120nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50:  1.00E+3nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetPro-cathepsin H(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50:  6.38E+3nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetLys-gingipain(Porphyromonas gingivalis)
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50:  0.120nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain (Kgp) were measured in a fluorogenic assay similar t...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50:  1.00E+3nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetPro-cathepsin H(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50:  6.38E+3nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Cortexyme

US Patent
LigandPNGBDBM453331(BDBM553834 | US10730826, Compound 55a)
Affinity DataIC50: >1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent